Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma

BACKGROUND: Primary pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare subtype of non-small cell lung cancer (NSCLC), and no effective treatments have been defined for advanced disease. Programmed cell death-ligand 1 (PD-L1) is expressed in a group of cancers that may be suitable targets fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Li, Wang, Liang, Li, Peng-fei, Zhang, Xin-ke, Chen, Jie-wei, Qiu, Hui-juan, Wu, Xiao-dong, Zhang, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474388/
https://www.ncbi.nlm.nih.gov/pubmed/26109869
http://dx.doi.org/10.2147/OTT.S84234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474388/
https://www.ncbi.nlm.nih.gov/pubmed/26109869
http://dx.doi.org/10.2147/OTT.S84234

Ejemplares similares